BackSupernus Pharmaceuticals Overview
Supernus Pharmaceuticals Inc

Supernus Pharmaceuticals Target Price

Analysts' 12-month price predictions for SUPN.

Get informed when a big investor buys or sells

+ Follow

Share Price

$44.48

Average Target Price

$65.0046.1% upside

1 analysts in the last 4 months

High: $65 | Low: $65

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-02-25Craig-Hallum$6546.1% upsideOpen
2025-12-19Stifel NicolausAnnabel Samimy$5523.7% upsideOpen
2025-10-08Piper Sandler$6546.1% upsideOpen
2025-09-30Cantor Fitzgerald$6341.6% upsideOpen
2025-08-29Piper Sandler$4010.1% downsideOpen
2025-07-29Cantor Fitzgerald$425.6% downsideOpen
2024-09-11Piper SandlerDavid Amsellem$3619.1% downsideOpen
2024-05-24Piper SandlerDavid Amsellem$417.8% downsideOpen
2024-04-08JefferiesIrene Buhalo$4010.1% downsideOpen
2024-04-08Stifel NicolausAnnabel Samimy$3814.6% downsideOpen